Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

ALMS

Live52w high -25.3%

Loading latest news…

☁️ News word cloud

Top words across the last 50 articles for this ticker.

alumisacelyrinmergerclinicalpsoriasispipelinestagetherapiesstockholderscombinedphaseimmunemediateddiseasesagreementbiopharmaannouncedlatecreatefinancial

Loading latest news…

52w high -25.3%

☁️ News word cloud

Top words across the last 50 articles for this ticker.

alumisacelyrinmergerclinicalpsoriasispipelinestagetherapiesstockholderscombinedphaseimmunemediateddiseasesagreementbiopharmaannouncedlatecreatefinancial